TheraPEAK™ LV Cartridge, weldable

The Nucleofector^TM Technology from Lonza is based on two main components. The first is the Nucleofector^TM Device, which offers a unique portfolio of electrical parameters, displayed as distinct programs that are adapted to the requirements of specific cell types. This means that the user does not need to optimize the pulse parameters manually (saving a lot of time, cells and reagents). The second component is provided via a range of Nucleofector^TM Kits, each of which contains cell type-specific Nucleofector^TM solutions, cuvettes and pipettes.